Form 8-K - Current report:
SEC Accession No. 0001193125-25-303162
Filing Date
2025-12-01
Accepted
2025-12-01 08:00:13
Documents
12
Period of Report
2025-11-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d57660d8k.htm   iXBRL 8-K 29506
  Complete submission text file 0001193125-25-303162.txt   144984

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tyra-20251125.xsd EX-101.SCH 2827
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyra-20251125_lab.xml EX-101.LAB 17976
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyra-20251125_pre.xml EX-101.PRE 11242
14 EXTRACTED XBRL INSTANCE DOCUMENT d57660d8k_htm.xml XML 3629
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

EIN.: 831476348 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40800 | Film No.: 251537172
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)